Breath test to check mesothelioma treatment response
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a special breath test (called an e-nose) to see if it can tell how well your treatment is working for malignant pleural mesothelioma. It is a non-invasive way to monitor your response to therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 85 years old.
- You have never had cancer in the chest, breast, stomach, colon, or pancreas.
- You have been recently diagnosed with malignant pleural mesothelioma.
- You are willing to sign consent forms for the research and for surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether adding nivolumab (an immunotherapy) to a one-time “light-based” treatment during a lung procedure can control malignant pleural mesothelioma that can’t be surgically removed. You may be eligible if your cancer has come back or progressed after prior platinum chemotherapy, and if your tumor is reachable for the light treatment during thoracoscopy.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
This trial uses a special breath test (E-Nose) to monitor how well treatment is working in people with non-small cell lung cancer. You just breathe into a device, and it measures compounds in your breath.
This trial studies how well pembrolizumab (an immune therapy) works when added to chemotherapy before image-guided surgery for malignant pleural mesothelioma. It aims to shrink or control the cancer and improve surgical results by combining treatments.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This trial uses a test on your tumor tissue to find which chemotherapy drugs work best for you, after standard surgery and heated chemotherapy. It aims to make your treatment more effective by choosing drugs that match your cancer.
Hear when a new Malignant Pleural Mesothelioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.